{
    "2020-03-25": [
        [
            {
                "time": "2019-03-25",
                "original_text": "药明康德：境外“长尾客户”、CDMO业务奠定增长基础",
                "features": {
                    "keywords": [
                        "药明康德",
                        "CDMO业务",
                        "长尾客户",
                        "增长基础"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-25",
                "original_text": "CXO企业维持高速增长疫情不影响行业长期发展逻辑",
                "features": {
                    "keywords": [
                        "CXO企业",
                        "高速增长",
                        "疫情",
                        "长期发展逻辑"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-25",
                "original_text": "鹰眼预警：药明康德盈利能力下滑 现金流净流出 盈利能力下降",
                "features": {
                    "keywords": [
                        "药明康德",
                        "盈利能力",
                        "现金流",
                        "下降"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-03-25",
                "original_text": "7只股获北向资金连续净买入",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-25",
                "original_text": "药明康德去年营收涨超33% 拟定增65亿投入药物生产研发",
                "features": {
                    "keywords": [
                        "药明康德",
                        "营收",
                        "增长",
                        "定增",
                        "药物生产研发"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-25",
                "original_text": "市值超1500亿 药明康德未来潜力在哪里？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "市值",
                        "未来潜力"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-25",
                "original_text": "港股异动︱年度净利下降18% 每10股转增4股派3.37元 药明康德(02359)现涨6% 盈利能力下降",
                "features": {
                    "keywords": [
                        "药明康德",
                        "净利下降",
                        "分红",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}